{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:21:52Z","timestamp":1758709312415,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Centre, Poland","award":["UMO-2013\/11\/D\/NZ7\/01170"],"award-info":[{"award-number":["UMO-2013\/11\/D\/NZ7\/01170"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.pharep.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T02:49:59Z","timestamp":1546742999000},"page":"299-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model"],"prefix":"10.1007","volume":"71","author":[{"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Marzeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Gut-Lepiech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria W.","family":"Kondrat-Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Wr\u00f3blewska-\u0141uczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Karwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Plech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2019.01.003_bib0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","article-title":"Incidence of epilepsy: a systematic review and meta-analysis","volume":"77","author":"Ngugi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharep.2019.01.003_bib0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2019.01.003_bib0015","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.pharep.2019.01.003_bib0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2019.01.003_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","article-title":"Diverse mechanisms of antiepileptic drugs in the development pipeline","volume":"69","author":"Rogawski","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2019.01.003_bib0030","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1734-1140(12)70893-9","article-title":"Influence of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of 4 classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"64","author":"Luszczki","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2019.01.003_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2012.06.023","article-title":"Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"690","author":"Luszczki","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2019.01.003_bib0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.7150\/ijms.20001","article-title":"Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione \u2013 a novel anticonvulsant drug candidate","volume":"14","author":"Kapron","year":"2017","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.pharep.2019.01.003_bib0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejmech.2014.09.034","article-title":"Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system","volume":"86","author":"Plech","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.01.003_bib0050","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.3390\/molecules190811279","article-title":"Studies on the anticonvulsant activity and influence on GABA-ergic neurotransmission of 1,2,4-triazole-3-thione- based compounds","volume":"19","author":"Plech","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.pharep.2019.01.003_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmech.2012.11.026","article-title":"Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles","volume":"60","author":"Plech","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2019.01.003_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2019.01.003_bib0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"Loscher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.pharep.2019.01.003_bib0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5114\/hpc.2016.58209","article-title":"Interaction of three-drug combination of lacosamide, carbamazepine and phenobarbital in the mouse maximal electroshock-induced seizure model \u2013 an isobolographic analysis","volume":"10","author":"Kondrat-Wrobel","year":"2016","journal-title":"Health Prob Civil"},{"key":"10.1016\/j.pharep.2019.01.003_bib0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/hpc.2016.63572","article-title":"Isobolographic assessment of interactions between retigabine and phenytoin in the mouse maximal electroshock-induced seizure model and chimney test","volume":"10","author":"Zolkowska","year":"2016","journal-title":"Health Prob Civil"},{"key":"10.1016\/j.pharep.2019.01.003_bib0080","first-page":"99","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2019.01.003_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5114\/hpc.2017.70010","article-title":"Anticonvulsant potency of 10 various p-isopropoxyphenylsuccinimide derivatives in the maximal electroshock-induced seizure threshold model in mice","volume":"11","author":"Kocharov","year":"2017","journal-title":"Health Prob Civil"},{"key":"10.1016\/j.pharep.2019.01.003_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pharep.2015.09.003","article-title":"Assessment of the anticonvulsant potency of various benzylamide derivatives in the mouse maximal electroshock-induced seizure threshold model","volume":"68","author":"Swiader","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2019.01.003_bib0095","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pharep.2019.01.003_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2003.08.003","article-title":"Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics\u2013a comparative study","volume":"56","author":"Luszczki","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharep.2019.01.003_bib0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000114870","article-title":"Interactions of MRZ 2\/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model","volume":"81","author":"Luszczki","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharep.2019.01.003_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.193474","article-title":"Revisiting the isobole and related quantitative methods for assessing drug synergism","volume":"342","author":"Tallarida","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2019.01.003_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2019.01.003_bib0120","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.0013-9580.2004.09604.x","article-title":"Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice","volume":"45","author":"Borowicz","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2019.01.003_bib0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2019.01.003_bib0130","first-page":"93","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharep.2019.01.003_bib0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF00500017","article-title":"Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin","volume":"333","author":"Bourgeois","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2019.01.003_bib0140","first-page":"8","article-title":"Response surface analysis of synergism between morphine and clonidine","volume":"289","author":"Tallarida","year":"1999","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018304717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018304717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:52Z","timestamp":1752611872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2019.01.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1734114018304717"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2019.01.003","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}